# Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

> **NCT03739684** · PHASE3 · COMPLETED · sponsor: **Progenics Pharmaceuticals, Inc.** · enrollment: 208 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma
- Prostate Cancer Recurrent
- Prostate Cancer Metastatic

## Interventions

- **DRUG:** 18F-DCFPyL
- **DIAGNOSTIC_TEST:** PET/CT Imaging

## Key facts

- **NCT ID:** NCT03739684
- **Lead sponsor:** Progenics Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-27
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-08-29
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739684, "Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03739684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*